TGI is pleased to announce that the FDA has granted clearance for the clinical trial of TGI-6, its groundbreaking bispecific antibody...
Science and Technology Department of Anhui Province recently announced the list of the second batch of National Science and Technology-based Small and Medium-sized Enterprises in 2022 in which TG ImmunoPharma, as an invisible unicorn company in the field of tumor immunotherapy...
TG ImmunoPharma, specializing in NK (Natural Killer) cell-based checkpoint immunotherapy drugs, is uncovering the linchpin of the next-generation method of treating cancer with the fresh funding...
On November 26, 2021, the 2nd session of China's Top 500 Hidden Unicorn Conference (2021) co-sponsored by the People's Government of Hefei Municipality and China Private Enterprise Research Center…
ICP备字:皖ICP备2022011087号-1 (皖)-非经营性-2022-0075 皖公网安备 34019102001077号 ©Copyright by CSPC All rights reserved.